Last week, the British alt-rockers announced a 30-date tour across the US – their first extensive U.S. run of dates since 2019 – which will kick-off at New Orleans’ Smoothie King Center on 10 May, and conclude at Florida’s Miami-Dade Arena on 1 July. But yet another big tour announcement to get fans giddy has been beset by the seemingly never-ending saga over how to purchase tickets – and chiefly, over the principal ticket operator, Ticketmaster. Writing on Twitter, The Cure’s frontman called out the operator after the tickets went on sale, and was keen to emphasise the autonomy Ticketmaster have over the pricing.
“I am as sickened as you all are by today’s Ticketmaster ‘fees’ debacle,” Smith wrote. “To be very clear: the artist has no way to limit them. I have been asking how they are justified. If I get anything coherent by way of an answer I will let you all know.” Smith has vowed to keep prices for The Cure’s shows low, and in an email to fans said the band have agreed “there will be no ‘platinum’ or ‘dynamically priced’ tickets on this tour”, aside from a few charity seats at the Hollywood Bowl show. And Smith is by no means the only high-profile artist to take aim at Ticketmaster of late. In November, there was huge uproar from legions of disappointed Swifties by the way the ticket distributor handled the sale of tickets for Taylor Swift’s ‘The Eras Tour’.I AM AS SICKENED AS YOU ALL ARE BY TODAY'S TICKETMASTER 'FEES' DEBACLE. TO BE VERY CLEAR: THE ARTIST HAS NO WAY TO LIMIT THEM. I HAVE BEEN ASKING HOW THEY ARE JUSTIFIED. IF I GET ANYTHING COHERENT BY WAY OF AN ANSWER I WILL LET YOU ALL KNOW. X
— ROBERT SMITH (@RobertSmith) March 16, 2023

Photo: Kevin Winter
